4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Neoplasms in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Besides cardiovascular diseases, cancer represents the major cause of death in developed countries." | 1.36 | A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease. ( Götz, C; Gratz, A; Jose, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gratz, A | 1 |
| Götz, C | 1 |
| Jose, J | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Neoplasms
| Article | Year |
|---|---|
A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Topics: Casein Kinase II; Emodin; Enzyme Assays; Fluorescence; Fluorescence Resonance Energy Transfer; Human | 2010 |